Biologics contract manufacturing, or BCM, refers to the collaboration between a pharmaceutical company and a specialised third-party service provider, known as a contract development and ...

Get insights from the Bio/Pharmaceutical Outsourcing Report, a comprehensive monthly analysis of trends and news impacting pharmaceutical CMOs.. Essential for CMO execs, procurement leaders, investors ...

Pharmaceutical CGMP manufacturing refers to producing pharmaceutical products under regulatory guidelines that ensure product quality, safety, and efficacy. CGMP guidelines encompass a wide range of ...

Nationally, pharmaceutical manufacturing technicians can expect to start at about $16 per hour, and the median compensation is about $21 per hour, according to Payscale, a compensation-data firm.

Digital Supply Chain And Manufacturing Management McKinsey has estimated that, in terms of investment volume, supply chain management and manufacturing is the second-largest sector after marketing ...

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...

Contract Manufacturing in Pharmaceutical Industry, 2015-2025 - North America and Europe are the predominant regions where majority of the production facilities of CMOs are located Dec 10, 2015 8:37am ...

A pharmaceutical development, manufacturing and packaging giant which employs thousands of people across the globe has struck a deal to open a new facility in the East Midlands.

Image Credit: Quality Stock Arts/Shutterstock.com Batch vs. continuous manufacturing For many years, the pharmaceutical industry was hesitant to incorporate continuous manufacturing into their ...

Pharmaceutical manufacturers are increasingly interested in the tenets of Industry 4.0, including the use of digital twins to simulate, test and optimize manufacturing processes on a computer ...

Aurisco Pharmaceutical's manufacturing facility in Yangzhou passed a USFDA inspection in August 2023 and leverages state-of-the-art infrastructure and the highest standards of current Good ...

One U.S. jurisdiction that is ready and in a perfect position to partner in this effort is Puerto Rico, where pharmaceutical manufacturing is already a more than $50 billion industry.